Starting or Strengthening a Drug Bulletin - A Practical Manual
(2005; 165 pages) View the PDF document
Table of Contents
View the documentPreface
View the documentHow the manual was produced
View the documentAbout ISDB
View the documentExecutive summary
Open this folder and view contents1. Introduction
Open this folder and view contents2. Rational use of medicines
Open this folder and view contents3. What are drug bulletins?
Open this folder and view contents4. Defining aims, target and type of bulletin
Open this folder and view contents5. Planning resources
Open this folder and view contents6. Planning bulletin production: schedules and timing
Close this folder7. The editorial process
View the document7.1 Outline of the editorial process
Open this folder and view contents7.2 Editing a drug bulletin
Open this folder and view contents7.3 Writing bulletin articles
Open this folder and view contents7.4 Reviewing the article
View the document7.5. Rewriting the article
View the document7.6 Final checks
Open this folder and view contents7.7 Follow-up after publication
View the document7.8 References
Open this folder and view contents8. Reviewing a new drug: is it a therapeutic advance?
Open this folder and view contentsAnnexe to Chapter 8: Evaluating harm
Open this folder and view contents9. Design and production
Open this folder and view contents10. Dissemination
Open this folder and view contents11. Organizational and legal issues
Open this folder and view contents12. Evaluating quality and usefulness
Open this folder and view contents13. Partnership and collaboration
Open this folder and view contents14. Keeping records and creating a memory
Open this folder and view contentsAppendix: Electronic sources of information
 

7.8 References

1. WHO Regional Office for Europe. Definition of independent drug information. In: Independent drug bulletins. Report of an international WHO meeting on drug information, Madrid 1985:

2. International Society of Drug Bulletins Constitution. Articles of the Society. 31 March 1987.

3. Comment établir l'imputabilité des effets indésirables des médicaments? (How can we determine the causes of adverse effects of drugs?) La Lettre du Cedim 1998;3(1).

4. Ahlquist-Rastad J, et al. Judging the therapeutic value of drugs: a comparison between la revue Prescrire and Information fran Läkemedelsverket, the bulletin of the Swedish Medical Products Agency. International Journal of Risk & Safety in Medicines 2004;16:83-90.

5. Commissioning and writing. In: How to produce a newsletter. Rev. ed. London: Healthlink Worldwide; 1998. (Out of print, but a scanned version is available at:
http://mednet2.who.int/DrugBulletinProject/).

6. Reading between the lines of clinical trials-I: design. Drug and Therapeutics Bulletin 1985;23:1-4 and “II: analysis” Drug and Therapeutics Bulletin 1985;23:5-8.

7. Greenhalgh T. How to read a paper. The basics of evidence based medicine. London: BMJ Publishing Group; 1997.

 

to previous section
to next section
 
 
The WHO Essential Medicines and Health Products Information Portal was designed and is maintained by Human Info NGO. Last updated: August 29, 2014